[2]
Mahant N,Clouston PD,Lorentz IT, The current use of botulinum toxin. Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia. 2000 Sep; [PubMed PMID: 10942658]
[3]
Patel KB,Cai S,Adler M,Singh BK,Parmar VS,Singh BR, Natural Compounds and Their Analogues as Potent Antidotes against the Most Poisonous Bacterial Toxin. Applied and environmental microbiology. 2018 Dec 15; [PubMed PMID: 30389764]
[4]
Bentivoglio AR,Del Grande A,Petracca M,Ialongo T,Ricciardi L, Clinical differences between botulinum neurotoxin type A and B. Toxicon : official journal of the International Society on Toxinology. 2015 Dec 1; [PubMed PMID: 26260691]
[5]
Patil S,Willett O,Thompkins T,Hermann R,Ramanathan S,Cornett EM,Fox CJ,Kaye AD, Botulinum Toxin: Pharmacology and Therapeutic Roles in Pain States. Current pain and headache reports. 2016 Mar [PubMed PMID: 26879873]
[7]
Coté TR,Mohan AK,Polder JA,Walton MK,Braun MM, Botulinum toxin type A injections: adverse events reported to the US Food and Drug Administration in therapeutic and cosmetic cases. Journal of the American Academy of Dermatology. 2005 Sep; [PubMed PMID: 16112345]
[8]
Walker TJ,Dayan SH, Comparison and overview of currently available neurotoxins. The Journal of clinical and aesthetic dermatology. 2014 Feb [PubMed PMID: 24587850]
[9]
Godoy IR,Donahue DM,Torriani M, Botulinum Toxin Injections in Musculoskeletal Disorders. Seminars in musculoskeletal radiology. 2016 Nov; [PubMed PMID: 28002866]
[10]
Luvisetto S,Gazerani P,Cianchetti C,Pavone F, Botulinum Toxin Type a as a Therapeutic Agent against Headache and Related Disorders. Toxins. 2015 Sep 23; [PubMed PMID: 26404377]
[11]
Dressler D,Saberi FA,Barbosa ER, Botulinum toxin: mechanisms of action. Arquivos de neuro-psiquiatria. 2005 Mar; [PubMed PMID: 15830090]
[14]
Zakin E,Simpson D, Evidence on botulinum toxin in selected disorders. Toxicon : official journal of the International Society on Toxinology. 2018 Jun 1; [PubMed PMID: 29408357]
[15]
Field M,Splevins A,Picaut P,van der Schans M,Langenberg J,Noort D,Snyder D,Foster K, AbobotulinumtoxinA (Dysport{sup}®{/sup}), OnabotulinumtoxinA (Botox{sup}®{/sup}), and IncobotulinumtoxinA (Xeomin{sup}®{/sup}) Neurotoxin Content and Potential Implications for Duration of Response in Patients. Toxins. 2018 Dec 13; [PubMed PMID: 30551641]
[16]
Kattimani V,Tiwari RVC,Gufran K,Wasan B,Shilpa PH,Khader AA, Botulinum Toxin Application in Facial Esthetics and Recent Treatment Indications (2013-2018). Journal of International Society of Preventive [PubMed PMID: 31058058]
[18]
Arnon SS,Schechter R,Inglesby TV,Henderson DA,Bartlett JG,Ascher MS,Eitzen E,Fine AD,Hauer J,Layton M,Lillibridge S,Osterholm MT,O'Toole T,Parker G,Perl TM,Russell PK,Swerdlow DL,Tonat K, Botulinum toxin as a biological weapon: medical and public health management. JAMA. 2001 Feb 28; [PubMed PMID: 11209178]
[19]
Khouri JM,Motter RN,Arnon SS, Safety and immunogenicity of investigational recombinant botulinum vaccine, rBV A/B, in volunteers with pre-existing botulinum toxoid immunity. Vaccine. 2018 Apr 5; [PubMed PMID: 29475762]
[20]
Castelão M,Marques RE,Duarte GS,Rodrigues FB,Ferreira J,Sampaio C,Moore AP,Costa J, Botulinum toxin type A therapy for cervical dystonia. The Cochrane database of systematic reviews. 2017 Dec 12; [PubMed PMID: 29230798]
[21]
Herd CP,Tomlinson CL,Rick C,Scotton WJ,Edwards J,Ives N,Clarke CE,Sinclair A, Botulinum toxins for the prevention of migraine in adults. The Cochrane database of systematic reviews. 2018 Jun 25; [PubMed PMID: 29939406]
[22]
Jackson JL,Kuriyama A,Hayashino Y, Botulinum toxin A for prophylactic treatment of migraine and tension headaches in adults: a meta-analysis. JAMA. 2012 Apr 25; [PubMed PMID: 22535858]
[23]
Jia Z,Lu H,Yang X,Jin X,Wu R,Zhao J,Chen L,Qi Z, Adverse Events of Botulinum Toxin Type A in Facial Rejuvenation: A Systematic Review and Meta-Analysis. Aesthetic plastic surgery. 2016 Oct; [PubMed PMID: 27495260]